TSOI focuses on excellence rather than on competi
Post# of 208
(Total Views: 516)
Posted On: 10/01/2020 6:04:08 AM
TSOI focuses on excellence rather than on competition
Amidst the euphoria of new developments almost every week at TSOI, which includes STEMVACS, JADICELL, NEUROLEUKIN, QUADRAMUNE wherein TSOI has already demonstrated enough in their pre-clnicals and phase I regarding safety and efficacy of all the above products on COVID-19, CANCER, RA, DEPRESSION, PARKINSONS, ALZHEIMERS and SUICIDE prone patients.
Now as we await the enrollment to begin in QM clinical Phase II trial with 500 patients and inventory is almost ready to be distributed to the various medical hospital locations, lets throw some views on what Nanostilbene (NS) can play role in cancer treatment.
NanoStilbene - A potent adjuvant Drug in treatment of all Cancers
A total of 1,806,590 new cancer cases and 606,520 deaths are expected in the US in 2020, which is about 4,950 new cases and more than 1,600 deaths each day.
Among the 30% of dying patient population if NanoStilbene (NS) is prescribed to those patients as an adjuvant drug along with FDA approved chemotherapy drug like HERCEPTIN since NS has already been proven to reduce the cancer inflammation levels by 50% or so.
Now Even if let's say only 30% of dying cancer patient population (i.e 180,000) use NanoStilbene (NS) in their Chemotherapy, as per CEO of TSOI this will require 1 gallon of nanostilbene to almost treat 7 patients for one year. Lets say Tim Dixon can make about 25000 gallons in a year, then 25,000 x 7 = 175,000 rounded to 180,000 patients.
As per Tim Dixon the CEO of TSOI will be able to sell Nanostilbene (NS) at rate of $23000 per gallon which translate into $23000 X 25000 gallons = 575 million USD per year
I sincerely believe TSOI will have multiple sales and marketing campaigns to reach out to the target cancer population of 180,000 at least and save their lives from now on.
This kind of strategy will catapult TSOI into a BIG PHARMA company and the sales from NS will fund all its products in the present pipeline and make it reach to the pinnacle of its business plan. I pray that all the cancer patients will survive from death and be able to live their lives to the fullest extent.
Amidst the euphoria of new developments almost every week at TSOI, which includes STEMVACS, JADICELL, NEUROLEUKIN, QUADRAMUNE wherein TSOI has already demonstrated enough in their pre-clnicals and phase I regarding safety and efficacy of all the above products on COVID-19, CANCER, RA, DEPRESSION, PARKINSONS, ALZHEIMERS and SUICIDE prone patients.
Now as we await the enrollment to begin in QM clinical Phase II trial with 500 patients and inventory is almost ready to be distributed to the various medical hospital locations, lets throw some views on what Nanostilbene (NS) can play role in cancer treatment.
NanoStilbene - A potent adjuvant Drug in treatment of all Cancers
A total of 1,806,590 new cancer cases and 606,520 deaths are expected in the US in 2020, which is about 4,950 new cases and more than 1,600 deaths each day.
Among the 30% of dying patient population if NanoStilbene (NS) is prescribed to those patients as an adjuvant drug along with FDA approved chemotherapy drug like HERCEPTIN since NS has already been proven to reduce the cancer inflammation levels by 50% or so.
Now Even if let's say only 30% of dying cancer patient population (i.e 180,000) use NanoStilbene (NS) in their Chemotherapy, as per CEO of TSOI this will require 1 gallon of nanostilbene to almost treat 7 patients for one year. Lets say Tim Dixon can make about 25000 gallons in a year, then 25,000 x 7 = 175,000 rounded to 180,000 patients.
As per Tim Dixon the CEO of TSOI will be able to sell Nanostilbene (NS) at rate of $23000 per gallon which translate into $23000 X 25000 gallons = 575 million USD per year
I sincerely believe TSOI will have multiple sales and marketing campaigns to reach out to the target cancer population of 180,000 at least and save their lives from now on.
This kind of strategy will catapult TSOI into a BIG PHARMA company and the sales from NS will fund all its products in the present pipeline and make it reach to the pinnacle of its business plan. I pray that all the cancer patients will survive from death and be able to live their lives to the fullest extent.
(0)
(0)Therapeutic Solutions International Inc (TSOI) Stock Research Links
Scroll down for more posts ▼